Product Description: (3aR)-Selitrectinib ((3aR)-LOXO-195) is an isform of Selitrectinib (HY-101977), which is a next-generation TRK kinase inhibitor, with IC50s of 0.6 nM and TRKA and TRKC, respectively[1].
Applications: Cancer-Kinase/protease
Formula: C20H21FN6O
References: [1]Drilon A, et al. A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors. Cancer Discov. 2017 Sep;7(9):963-972.
CAS Number: 1350884-56-8
Molecular Weight: 380.42
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Trk Receptor